Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Endocrine 2

Conditions

Squamous Cell Carcinoma of Head and Neck 37Head and Neck Neoplasms 28Prostatic Neoplasms 16Oropharyngeal Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Uterine Cervical Neoplasms 8Gliosarcoma 8Glioblastoma 8Carcinoma, Squamous Cell 7Brain Neoplasms 7Tongue Neoplasms 6Rectal Neoplasms 6Pancreatic Neoplasms 5Lung Neoplasms 5Laryngeal Neoplasms 5Astrocytoma 5Papillomavirus Infections 4Neoplasm Metastasis 4Mouth Neoplasms 4Sarcoma 3Neoplasms 3Hypopharyngeal Neoplasms 3Glioma 3Carcinoma 3Breast Neoplasms 3Urinary Bladder Neoplasms 2Thyroid Carcinoma, Anaplastic 2Stomatitis 2Rhabdomyosarcoma 2Radiation Injuries 2

Interventions

Paclitaxel 4pembrolizumab 2pazopanib 2efatutazone 2Sorafenib 2Radiotherapy, Intensity-Modulated 2trametinib 1tislelizumab 1surufatinib 1spartalizumab 1sapanisertib 1lenvatinib 1fosbretabulin 1dabrafenib 1crolibulin 1combretastatin 1cabozantinib 1atezolizumab 1abemaciclib 1Taxes 1Imatinib Mesylate 1Gefitinib 1Doxorubicin 1Docetaxel 1Cisplatin 1Carboplatin 1CUDC-907 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Thyroid Carcinoma, Anaplastic × Radiotherapy, Intensity-Modulated × Clear all
NCT01236547 2022-07-19

Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer

National Cancer Institute (NCI)

Phase 2 Completed
123 enrolled 24 charts
EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

NCT03211117 2020-03-25

Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer

Mayo Clinic

Phase 2 Completed
3 enrolled 7 charts
EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡